ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock News

USA - Nasdaq - NASDAQ:ASBP - US7389201077 - Common Stock

0.095 USD

-0.01 (-9.09%)

Last: 12/12/2025, 8:14:31 PM

0.1101 USD

+0.02 (+15.89%)

Pre-Market: 12/15/2025, 7:20:06 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ASBP Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: ACCESS Newswire

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

11 days ago - By: ACCESS Newswire

Aspire Biopharma Provides Q3 2025 Business Update

13 days ago - By: ACCESS Newswire

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

19 days ago - By: ACCESS Newswire

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

a month ago - By: Benzinga - Mentions: CANF IFRX ARVN OLMA ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

a month ago - By: Benzinga - Mentions: RYET ATGL MSS AMIX ...

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

a month ago - By: ACCESS Newswire

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

2 months ago - By: ACCESS Newswire

Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform

2 months ago - By: ACCESS Newswire

Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025